Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...

Telehealth company Hims & Hers Health (HIMS) witnessed a major dip in its stock recently despite reporting 95% revenue growth ...

Apostrophe, a Bay Area telehealth company focused on skin care, shut down after almost four years under the Hims & Hers ...

Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...

Hims & Hers (HIMS) stock falls 8% as court denies injunction on FDA ruling for Eli Lilly's (LLY) Zepbound shortage. Read more ...

Is the F.A.A. really ensuring safety by disqualifying pilots who receive a diagnosis or treatment? Troy Merritt, a pilot, ...

Hims & Hers (NYSE:HIMS ... Deep Value Returns' Marketplace continues to rapidly grow. Check out members' reviews. High-quality, actionable insightful stock picks. The place where value is everything.

Hims, Inc. has an A+ rating from the BBB as of February 2025. Most negative reviews are about products related to sexual health rather than hair loss. Many reviewers complain that they were still ...

Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to ...

Hims & Hers’ operations consist of two channels — Online Revenues and Wholesale Revenues. In the quarter under review, Online Revenues of $470.8 million reflected an increase of 98.3% year ...

Continue reading for our full review of Hims, with all of the nuances of their hair loss and prevention products examined along with a full evaluation and comparison to alternatives in the UK.